Learn about the key clinical features of AADC deficiency which may help to distinguish the condition from cerebral palsy, epilepsy, movement disorders, and other pediatric neurotransmitter disorders, which can have a similar presentation in the clinic
The core diagnostic tests for achieving a confirmational diagnosis are discussed
This is a summary of a virtual symposium hosted by PTC Therapeutics at the 2019 CNS Annual Meeting in Charlottesville, NC, USA. It was organized and funded by PTC Therapeutics; this meeting was not an official program of CNS 2019.
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-AADC-0702 | June 2021
Sign in or register to access exclusive content on this site
Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select one or more of the cookie types listed below, and then save your preferences. Refer to our Cookies Statement for more information.
Performance cookies, which help us measure the website’s performance and improve your experience. In using performance cookies we do not store any personal data, and only use the information collected through these cookies in aggregated and anonymised form.